Ovarian vein vs peripheral blood CA125 serum levels: A comparative study

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 71-74

  Podnos, Yale D ^a   Gamboa, Gisela ^a   Kurosaki, Tom ^a   Buller, Richard ^b   Walker, Joan L ^c   Manetta, Alberto ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; OVARIAN VEIN; OVARY CANCER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TUMOR VOLUME;

EID: 0031194828     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4712     Document Type: Article

References (17)

1. Cannistra S A. Cancer of the ovary. N Engl J Med. 329:1993;1550-1559.
2. R, C, Bast, M, Feeney, H, Lazarus, L, M, Nadler, R, B, Colvin, R, C, Knapp, Reactivity of a monoclonal antibody with human ovarian carcinoma, J Clin Invest, 69, 1331, 1337.
3. S, E, Kabawat, R, C, Bast, A, K, Bhan, W, R, Welch, R, B, Colvin, R, C, Knapp, Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125, Int J Gynecol Pathol, 2, 275, 285.
4. M, Dietel, H, Arps, R, Klapdor, S, Muller-Hagan, M, Sieck, L, Hoffmann, Antigen detection by monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patient's sera, J Cancer Res Clin Oncol, 111, 257, 265.
5. E, J, Nowen, D, E, Pollet, M, W, Eerdekens, P, G, Hendrix, T, W, Briers, M, E, de Broe, Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen and cancer antigen 125 in normal and neoplastic lung, Cancer Res, 46, 866, 876.
6. O'Riordan D K, Deery A, Dorman A, Epstein O E. Increased CA 125 in a patient with tuberculous peritonitis: case report and review of published works. Gut. 36:1995;303-305.
7. Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J, Ballesta A M. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem. 37:1991;1379-1383.
8. Collazos J, Genolla J, Ruibal A. CA 125 serum levels in patients with non-neoplastic liver diseases: a clinical and laboratory study. Scand J Clin Lab Invest. 52:1992;201-206.
9. Myers T J, Arena B, Granai C O. Pelvic endometriosis mimicking advanced ovarian cancer: presentation with pleural effusion, ascites, and elevated CA 125 level. Am J Obstet Gynecol. 173:1995;966-967.
10. Duk J M, De Bruijn H W, Grownier K H, Fleuren G J, Aalders J G. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics. Cancer. 65:1990;1830-1837.
11. Savandakou A, Kontovavdis A, Kontogeorgi Z, Rizos D, Phocas I. Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy. Eur J Obstet Gynecol Reprod Biol. 44:1992;215-220.
12. Buamah P K, Skillen A W. Serum CA 125 concentrations in patients with benign ovarian tumors. J Surg Oncol. 56:1994;71-74.
13. Lehtovirta P, Apter D, Stenman U H. Serum CA 125 levels during the menstrual cycle. Br J Obstet Gynaecol. 97:1990;930-933.
14. Xu F J, Yu Y H, Daly L, DeSombre K, Anselmino L, Hass G M, Berchuck A, Soper J T, Clarke-Pearson D L, Boyer C, Loyfield L J, Bast R C. OVX1 radioimmunoassay complement CA125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures. J Clin Oncol. 11:1993;1506-1510.
15. Franchi M, Beretta P, Ghezzi F, Zanaboni F, Goddi A, Salvatore S. Diagnosis of pelvic masses with transabdominal color Doppler, CA125, and ultrasonography. Acta Obstet Gynecol Scand. 74:1995;734-739.
16. Tamakoshi K, Kikkawa F, Hasekawa N, Ishikawa H, Mizuno K, Kawai M, Tomoda Y. Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125. Gynecol Obstet Invest. 39:1995;125-129.
17. Tuxen M K, Soletormost G, Dombernowsky P. Tumor markers in the management of patients with ovarian cancer. Cancer Treat Rev. 21:1995;215-245.